LV Scar Burden (%) Calculator

Clinical calculation support · Verify results before clinical use

Scar burden calculation

Enter LV mass and scar mass from the same imaging assessment.

% Burden
Use the total LV myocardial mass in grams reported by the imaging analysis.
Enter the quantified scar or late gadolinium enhancement (LGE) mass in grams, using the same method and units.
Reset

About LV scar burden

LV scar burden expresses quantified scar mass as a proportion of total left ventricular mass. In cardiac magnetic resonance (CMR), scar or focal myocardial fibrosis is often assessed using late gadolinium enhancement (LGE). Results can vary with the acquisition protocol, image-processing approach, thresholding method, and disease substrate.

Formula

ParameterCalculation
LV scar burden (%)(Scar mass [g] ÷ total LV mass [g]) × 100

Important interpretation points

  • Use LV mass and scar mass obtained from compatible measurements and the same imaging analysis workflow.
  • There is no universally validated set of percentage bands that reliably classifies scar as “minimal,” “mild,” “moderate,” or “extensive” across all cardiomyopathies and imaging methods.
  • Greater LGE burden is associated with adverse outcomes in several populations, but the prognostic meaning of a given percentage is disease-specific and method-dependent.
  • Do not use this calculator alone to determine ICD/CRT eligibility or other treatment decisions.

Selected evidence

Kim RJ, Wu E, Rafael A, et al. The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction. N Engl J Med. 2000;343:1445–1453. DOI: 10.1056/NEJM200011163432003.
Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis. European Heart Journal. 2013. PubMed record: PMID 23558217.
Prediction of ventricular arrhythmias and sudden cardiac death by quantification and location of late gadolinium enhancement on cardiac magnetic resonance: a systematic review and meta-analysis. EP Europace. 2025;27(11):euaf214. DOI: 10.1093/europace/euaf214.
Clinical disclaimer: This calculator performs a mathematical calculation and does not establish a diagnosis or provide an individualized prognosis. LGE quantification methods and thresholds vary across diseases and studies. Interpret the result alongside the full CMR report and the patient's clinical context; do not use it as the sole basis for device therapy or other management decisions.